4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-22-053757
Chairman and CEO bought 97,500 shares at an average $0.18 ($17,200)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2022-10-13 | Purchase | +62,500 | $0.18 | $11,250 | 11,746,357 | D |
| Niihara Yutaka Chairman and CEO | 2022-10-14 | Purchase | +35,000 | $0.17 | $5,950 | 11,781,357 | D |
| Open-market purchases · 97,500 sh · avg $0.18 · $17,200 | |||||||
Loading xslF345X03/doc4.xml…